Jooyeon Oh
Overview
Explore the profile of Jooyeon Oh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le T, Kim Y, Lee K, Hong J, Oh J, Park Y, et al.
ACS Appl Mater Interfaces
. 2024 Oct;
16(50):69636-69644.
PMID: 39385727
As the chemical stability of organic materials in organic light-emitting diodes (OLEDs) greatly impacts devices' lifetime, a thoughtful and advanced design of materials and device structures is necessary. In our...
2.
Jeon D, Kim S, Kim J, Jeong H, Uhm C, Oh H, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jul;
1870(7):167347.
PMID: 39019092
Intranasal infection is commonly used to establish a SARS-CoV-2 mouse model due to its non-invasive procedures and a minimal effect from the operation itself. However, mice intranasally infected with SARS-CoV-2...
3.
Kim J, Kim S, Kim J, Noh H, Lee S, Jeong H, et al.
Immune Netw
. 2024 May;
24(2):e7.
PMID: 38725670
Viral load and the duration of viral shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are important determinants of the transmission of coronavirus disease 2019. In this study, we...
4.
Ali M, Park I, Kim J, Kim G, Oh J, You J, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137356
The integration of artificial intelligence (AI) into drug discovery has markedly advanced the search for effective therapeutics. In our study, we employed a comprehensive computational-experimental approach to identify potential anti-SARS-CoV-2...
5.
Choi S, Lee J, Kim S, Lee Y, Kim G, Hong S, et al.
EBioMedicine
. 2023 Dec;
99:104932.
PMID: 38118400
Background: The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to approximately 500 million cases and 6 million deaths worldwide. Previous investigations into the pathophysiology...
6.
Kwak M, Choi S, Kim J, Lee H, Park I, Oh J, et al.
Immune Netw
. 2023 Jul;
23(3):e26.
PMID: 37416931
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces excessive pro-inflammatory cytokine release and cell death, leading to organ damage and mortality. High-mobility group box 1 (HMGB1) is one of...
7.
Noh H, Yoon S, Kim S, Kim J, Seo J, Kim J, et al.
Pulm Pharmacol Ther
. 2023 Jan;
80:102189.
PMID: 36634813
Throughout the recent COVID-19 pandemic, South Korea led national efforts to develop vaccines and therapeutics for SARS-CoV-2. The project proceeded as follows: 1) evaluation system setup (including Animal Biosafety Level...
8.
Kim S, Kim J, Jang J, Noh H, Park J, Jeong H, et al.
Front Immunol
. 2022 Dec;
13:1105713.
PMID: 36532025
[This corrects the article DOI: 10.3389/fimmu.2022.1055811.].
9.
Kim S, Kim J, Jang J, Noh H, Park J, Jeong H, et al.
Front Immunol
. 2022 Dec;
13:1055811.
PMID: 36457995
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) has been a global health concern since 2019. The viral spike protein infects the host by binding to...
10.
Temporal Transcriptome Analysis of SARS-CoV-2-Infected Lung and Spleen in Human ACE2-Transgenic Mice
Kim J, Kim S, Seo J, Noh H, Jeong H, Kim J, et al.
Mol Cells
. 2022 Nov;
45(12):896-910.
PMID: 36324270
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and potentially fatal virus. So far, most comprehensive analyses encompassing clinical and transcriptional manifestation have concentrated on the lungs....